Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Tengelmann, Caroline; Joos, Stefanie; Kaussner, Yvonne; Malzahn, Uwe; Lunden, Laura; Klug, Andreas; Hausler, Karl Georg; Escales, Catharina; Maetzler, Walter; Hugen, Klemens; Zolk, Oliver; Heuschmann, Peter U.; Forster, Christian; Kaduszkiewicz, Hanna; Gagyor, Ildiko

Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Autor(en):

Tengelmann, Caroline; Joos, Stefanie; Kaussner, Yvonne; Malzahn, Uwe; Lunden, Laura; Klug, Andreas; Hausler, Karl Georg; Escales, Catharina; Maetzler, Walter; Hugen, Klemens; Zolk, Oliver; Heuschmann, Peter U.; Forster, Christian; Kaduszkiewicz, Hanna; Gagyor, Ildiko

Tübinger Autor(en):

Joos, Stefanie
Förster, Christian

Erschienen in:

Bmc Infectious Diseases (2024), Bd. 24 (1), Article 56

Verlagsangabe:

London : Bmc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/s12879-023-08925-2

ISSN:

1471-2334